Penbrook Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,180
Closed -$98.7K 98
2025
Q3
$98.7K Sell
14,180
-18,155
-56% -$128K 0.07% 99
2025
Q2
$200K Buy
32,335
+14,180
+78% +$81.6K 0.08% 105
2025
Q1
$116K Buy
+18,155
New +$175K 0.09% 101

Other funds holding ASPN

Penbrook Management's ASPN Position: Q4 2025 in Review

Penbrook Management sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 14,180 shares — an estimated $98.7K sold.

Penbrook Management first reported a position in ASPN in Q1 2025 and held it in 3 quarters. The position peaked at $200K in Q2 2025. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Penbrook Management reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Penbrook Management sold 14,180 Aspen Aerogels shares in Q4 2025, an estimated $98.7K.
  • Penbrook Management first reported a position in Aspen Aerogels in Q1 2025 and held it in 3 quarters.
  • Penbrook Management's Aspen Aerogels position peaked at $200K in Q2 2025.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Penbrook Management's 13F filing for Q4 2025, filed 6 Jan 2026.